CD123-specific T cells were co-cultured with CD123+ primary AML cells for 72 hours, with CD19-specific CAR+ T cells used as a negative control, and target cytolysis was assessed by flow cytometry (Fig 4D). This evidence concerns the gene IL3RA and acute myeloid leukemia.